Nutritional immunology investigates the intricate bidirectional relationship between human nutritional status and immune system competence. Micronutrient deficienciesâeven at subclinical levelsâdirectly impair innate barrier defenses, antigen presentation, cytotoxic lymphocyte proliferation, and the resolution phase of inflammatory cascades.
Core Immunomodulatory Micronutrients
- Vitamin D3 (Cholecalciferol): Binds the nuclear Vitamin D Receptor (VDR) in monocytes and dendritic cells, inducing transcription of antimicrobial peptides (cathelicidin LL-37 and β-defensins).
- Zinc (Zn²âş): Essential cofactor for thymulin, DNA polymerase, and RNA polymerase; critical for maintaining mucosal epithelial junctional integrity and natural killer (NK) cell cytotoxicity.
- Selenium (Se): Incorporated into selenoproteins (glutathione peroxidases and thioredoxin reductases) that protect leukocytes from oxidative autolysis during respiratory burst.
- Ascorbic Acid (Vitamin C): Concentrates intracellularly in neutrophils up to 100-fold over plasma levels, enhancing chemotaxis, phagocytosis, and ROS scavenging.
Epithelial Barrier Defense and Secretory IgA Synthesis
Over 70% of human immune cells reside within gut-associated lymphoid tissue (GALT) and respiratory mucosal interfaces. Mucosal epithelial integrity depends on tight junction protein complexesâincluding claudins, occludins, and zonula occludens-1 (ZO-1).
Vitamin A (retinoic acid) directs mucosal homing receptor expression (α4β7 integrin and CCR9) on activated B and T lymphocytes, driving the differentiation of plasma cells that synthesize Secretory Immunoglobulin A (sIgA). sIgA performs immune exclusion, neutralizing viral and bacterial antigens without triggering destructive inflammatory tissue damage.
Immunonutrition Biomarker Targets & Clinical Ranges
| Biomarker | Deficiency / Insufficiency | Clinical Target / Sufficiency | Optimal Immune Function |
|---|---|---|---|
| Serum 25-Hydroxyvitamin D [25(OH)D] | < 30 ng/mL | 30 â 50 ng/mL | 50 â 70 ng/mL |
| RBC Zinc (µg/dL) | < 900 µg/dL | 900 â 1,200 µg/dL | 1,100 â 1,400 µg/dL |
| Serum Selenium (µg/L) | < 70 µg/L | 70 â 110 µg/L | 110 â 150 µg/L |
| Plasma Ascorbic Acid (mg/dL) | < 0.4 mg/dL | 0.4 â 0.8 mg/dL | 0.9 â 1.4 mg/dL |
Resolution of Inflammation and Specialized Pro-Resolving Mediators (SPMs)
The active termination of acute inflammation is regulated by Specialized Pro-Resolving Mediators (SPMs)âincluding resolvins, protectins, and maresins biosynthesized from omega-3 polyunsaturated fatty acids (EPA and DHA) via 15-lipoxygenase pathways.
SPMs actively stop neutrophil recruitment, promote non-phlogistic macrophage phagocytosis of apoptotic debris (efferocytosis), and accelerate mucosal tissue repair without causing systemic immunosuppression.
Frequently Asked Questions
What is the difference between serum zinc and RBC zinc testing?
Serum zinc accounts for <1% of total body stores and fluctuates with acute-phase reactions. Red blood cell (RBC) zinc reflects intracellular stores over the preceding 120 days, providing superior diagnostic precision.
Can high-dose single micronutrient supplementation create imbalances?
Yes. For instance, chronic zinc supplementation exceeding 40 mg/day without adequate copper can induce intestinal metallothionein, sequestering copper and leading to microcytic anemia and neutropenia.